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Abstract
Liver X activated receptor alpha (LXRα) forms a functional dimeric nuclear receptor with RXR that
regulates the metabolism of several important lipids, including cholesterol and bile acids. As
compared with RXR, the LXRα protein level in the cell is low and the LXRα protein itself is very
hard to detect. We have previously reported that the mRNA for LXRα is highly expressed in
human cultured macrophages. In order to confirm the presence of the LXRα protein in the human
macrophage, we have established a monoclonal antibody against LXRα, K-8607. The binding of
mAb K-8607 to the human LXRα protein was confirmed by a wide variety of different techniques,
including immunoblotting, immunohistochemistry, and electrophoretic mobility shift assay (EMSA).
By immunoblotting with this antibody, the presence of native LXR protein in primary cultured
human macrophage was demonstrated, as was its absence in human monocytes. This monoclonal
anti-LXRα antibody should prove to be a useful tool in the analysis of the human LXRα protein.
Background
Liver X activated receptor alpha (LXRα) was first identified
as an orphan member of the nuclear receptors expressed
mainly in the liver [1,2]. LXRα is highly expressed in liver,
intestine, kidney, spleen, Lung, and adipose tissue. LXRα
requires retinoid X receptors (RXRs) as a partner to recog-
nize and bind to its hormone response elements (HREs)
called LXRE, and regulates LXRE target gene expression in
a ligand dependent manner. LXRα has been shown to be
activated by a specific class of oxidized derivatives of cho-
lesterol [3,4].
Previously, we compared LXRα mRNA expression in vari-
ous internal organs using a DNA micro array and reported
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the highest level of mRNA expression in human macro-
phages differentiated from human monocytes in the pres-
ence of GM-CSF [5]. LXRα regulates the expression of
various genes in macrophages such as the ATP binding
cassette transporters (ABCA1, G1 / G4 / G8) [6–10], apol-
ipoproteins (ApoE / C-I / C-IV / C-II) [11,12], and lipo-
protein lipase (LPL) [13] in macrophages. LXRα also
regulates LXRα gene expression in macrophages [14–16].
The structure and function of the LXRα protein has been
studied in genetically engineered proteins or mammalian
cell expression systems, but little information is available
thus far on the physiologically expressed native protein.
Rat liver LXRα protein has been studied by means of an
antibody via immunoblotting [17,18] and electrophoretic
mobility supershift assay [3,19,20], but analysis of the na-
tive human LXRα protein has not been carried out due to
the lack of a sensitive anti-human LXRα monoclonal
antibody.
Recently we have initiated a project designed to carry out
a comprehensive analysis of the nuclear hormone recep-
tors using a cluster of anti-nuclear hormone receptor
monoclonal antibodies. Sensitive monoclonal antibodies
against PPAR proteins and the RXRα protein helped com-
plete an analysis of the native human PPAR proteins. We
have also established a monoclonal antibody against the
human LXRα protein, K-8607. Here we report the estab-
lishment and characterization of an anti-human LXRα
monoclonal antibody. By means of this monoclonal anti-
body, native human LXRα protein in human monocyte-
derived macrophage can be detected by immunoblotting.
This antibody can be used for electrophoretic mobility su-
pershift assay and immunostaining of COS-7 cells trans-
fected with a human LXRα expression vector.
Results
Specificity of the anti-human LXRα mAb, K-8607
Figure 1(A) indicates the immunoblot analysis of the spe-
cificity of the mAb K-8607. Nuclear extracts were obtained
form COS-7 cell transfected with human RXRα, LXRα or
LXRβ expression vectors. Nuclear extract from untransfect-
ed COS-7 cells were used as a control. In each lane, nucle-
ar extracts containing 20 ug of protein were
electrophoresed. The immunoblotting study indicated
that K-8607 bound specifically to a 50 kDa protein ex-
pressed in COS-7 cells transfected with an LXRα expres-
sion vector. The apparent molecular weight of this protein
is closely related to the calculated molecular weight of the
human LXRα protein. The previously reported antibodies
against LXRα have usually cross-reacted with LXRβ due to
the high similarity of the primary amino acid sequence of
both LXRs. In order to confirm the expression of LXRβ
protein in COS-7 cells, immunoblotting analysis using
mAb for human LXRβ K-8917 was performed. Figure 1(B)
indicates that a 55 kDa protein abundantly expressed in
COS-7 cells transfected with an LXRβ expression vector
and a small quantity of LXRβ protein was expressed inher-
ently in COS-7 cells. These results indicate that K-8607 is
specific to LXRα protein and does not recognize LXRβ.
K-8607 supershift electrophoretic mobility of the DR4 oli-
gonucleotide-nuclear extract protein complex
Figure 2 lanes 1 to 3 indicate the results of EMSA for syn-
thetic DR4 oligonucleotide and nuclear extracts from
COS-7 cells transfected with a human LXRα expression
vector. DR4, which is the consensus binding sequence for
human LXRα/RXR heterodimer complex, makes a com-
plex with protein(s) in nuclear extract from COS-7 cells
transfected with the LXRα expression vector (arrow I).
This complex was not detected when nuclear extract from
untransfected cells was used (data not shown). The band
disappeared upon addition of a 200-fold excess of unla-
beled DR4 oligonucleotide, indicating that the binding is
saturable (lane 2). The complex band did not change after
the addition of a 200-fold excess of mutated LXRE oligo-
nucleotide, which cannot bind to the LXRα / RXR het-
erodimer (lane 3).
Figure 1
Immunoblot detection of LXRα in transfected COS-7 
cells using anti-LXRα mAb and anti-LXRβ mAb 
Nuclear extracts of RXRα, LXRα and LXRβ transfected 
COS-7 cells (20 µg per lane) were separated on a SDS-poly-
acrylamide gel (10%), subjected to electrophoresis and trans-
ferred to PVDF membrane. (A) Anti-LXRα mAb was used as 
first antibody. Lanes: 1, untransfected; 2, RXRα; 3, LXRα; 4, 
LXRβ. (B) Anti-LXRβ mAb was used. Lanes: 1, untransfected; 
2, LXRβ.Nuclear Receptor 2003, 1 http://www.nuclear-receptor.com/content/1/1/1
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Lanes 4 to 6 indicate the results of supershift assay with
mAb K-8607. A higher molecular weight band (arrow II)
appeared upon the addition of 10 µg of mAb K-8607. This
higher molecular weight band disappeared with the addi-
tion of a 200-fold excess of unlabelled DR4 oligonucle-
otide. This band was not affected by the addition of a 200-
fold excess of mutated LXRE oligonucleotide. The original
DR4-nuclear extract complex (arrow I) did disappear with
the addition of mAb K-8607. These results indicate that
mAb K-8607 is able to recognize the complex formed by
DR4 and a component of nuclear extract from COS-7 cells
transfected with LXRα expression vector. These results
strongly suggest that mAb K-8607 is able to bind to the
DR4/LXRα complex.
Nuclear localization of mAb K-8607 antigen in COS-7 cells 
transfected with human LXRα expression vector
Figure 3 depicts the result of mAB K-8607 immunostain-
ing of COS-7 cells transfected with human LXRα expres-
sion vector. About one third of the transfected COS-7 cells
exhibited pronounced staining (left panel). At higher
magnification, the staining is clearly detectable in the nu-
cleus. COS-7 cells transfected with other expression vec-
tors did not indicate this nuclear staining (data not
shown). These results suggest that the antigen for mAb K-
8607 is located within the nucleus. These results suggest
the nuclear localization of human LXRα expressed in
COS-7 cells.
Detection of native human LXRα protein in human mono-
cyte-derived macrophages by mAb K-8607
Figure 4 depicts the results of the immunoblotting study
of human monocytes and macrophages using mAb K-
8607. Previously our investigation had indicated that
mRNA for LXRα is most abundantly expressed in human
monocyte-derived macrophages. MAb K-8607 is able to
detect human LXRα protein expressed in COS-7 cells. An
identical molecular weight protein can be detected in hu-
man monocyte-derived macrophages. This protein was
not detected in human monocytes, which express only a
very small amount of LXRα mRNA. These results suggest
that the 51 kDa protein detected by mAb K-8607 is native
human LXRα protein. The amount of native protein in
macrophages is significantly lower than in COS-7 cells ex-
pressing human LXRα protein.
Discussion
Analysis of the structure and function of the human LXRα
protein to date has been performed mainly with
genetically engineered proteins, since the analysis of na-
tive human LXRα protein has been hampered by the lack
of a sensitive monoclonal antibody against the LXRα pro-
tein. The mAb K-8607 was established with an N-terminal
94 amino acid sequence in a baculovirus expression sys-
tem. This monoclonal antibody recognizes a 51 kDa pro-
tein in nuclear extract from COS-7 cells, which is
consistent with the calculated molecular mass (49,000) of
the 447 amino-acid human LXRα protein.
A number of experimental results support the hypothesis
that the mAb K-8607 antigen is human LXRα. The se-
quence similarity of the human LXRα and LXRβ proteins
causes a specificity problem for establishing antibodies. In
order to overcome this problem, we selected the N-termi-
nal 94 amino acids. Within this region the similarity of
the amino acid sequences is relatively low (35% identity).
The results of immunoblotting indicated that mAb K-
8607 is able to specifically recognize LXRα. Additional ev-
idences further supports the specific recognition of the
LXRα protein by mAb K-8607.
Immunohistochemical studies with COS-7 cells transfect-
ed with a human LXRα expression vector indicated that
the antigen for mAb K-8607 is located in the nucleus. The
intracellular localization of human LXRα has not been re-
ported previously. Among the nuclear hormone receptors,
several proteins are known to be expressed in the nucleus,
Figure 2
Electrophoretic Mobility Shift Assay (EMSA) EMSA 
were performed with 10 µg whole cell extracts and a 10 fmol 
[gamma-32P] labeled probe. The specificity of binding to the 
respective probes was determined by using a 200-fold molar 
excess of unlabeled oligonucleotide as a competitor, which 
completely removed all the binding, indicating that these 
bound complexes resulted from sequence specific DNA-pro-
tein interactions. The arrows indicate the LXRα / RXRα 
complexes (i) and supershifted complexes (ii), respectively. 
Lanes: 1, LXRα / RXRα; 2, with the addition of unlabeled 
DR4 oligonucleotide; 3, with the addition of unlabeled 
mutated LXRE oligonucleotide; 4, supershifted complex; 5, 
with the addition of unlabeled DR4 oligonucleotide; 6, with 
the addition of unlabeled mutated LXRE oligonucleotide.Nuclear Receptor 2003, 1 http://www.nuclear-receptor.com/content/1/1/1
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but some of the receptors, including the glucocorticoid re-
ceptor are expressed in the cytoplasm and ligand binding
causes receptor translocation to the nucleus. In addition,
the EGFP fused to N-terminal portion of human LXRα can
be detected in the nucleus (Y. Watanabe et al manuscript
in preparation). These results support LXRα protein local-
ization in the nucleus.
Results of EMSA and supershift assay indicate that mAb K-
8607 can cause supershift of the complex formed by the
DR4 oligonucleotide binding sequence and nuclear ex-
tract protein from COS7-cells transfected with human
LXRα expression vector.
We next studied the recognition of native human LXRα
protein by mAb K-8607. We speculated that the difficulty
of native LXRα protein detection may be caused by the rel-
atively low level of native LXRα protein. We selected hu-
man monocyte-derived macrophages treated with GM-
CSF for 7 days as the source of native protein in order to
detect the native LXRα protein because this cell expresses
the highest level of LXRα mRNA according to our previous
investigations. The mRNA level in human monocyte-de-
rived macrophages is highest among the 8 tissues and cells
studied and the level is several fold higher than that in the
liver. The result of immunoblotting indicated that even in
monocyte-derived macrophages the level of the LXRα pro-
tein is very low as judged from the intensity of the immu-
noblot staining. In the case of the experiment shown in
Figure 4, we applied 2 ug of protein from COS-7 cells
transfected with human LXRα expression vector but we
needed to apply 75 ug of monocyte-derived macrophage
nuclear extract protein in order to detect the presence of
the 50 kDa protein. In the case of the RXRα protein, ordi-
narily it is possible to detect the native RXRα protein with
nearly the same amount of nuclear extract protein from
COS-7 cells transfected with human RXRα. This result sug-
gests that the level of native immunoreactive LXRα pro-
tein may be extremely low in human cells or tissues. We
were not able to detect the native LXRα protein in human
liver. This is not surprising because the mRNA level for
LXRα in human liver is several fold lower than that in
monocyte-derived macrophage. We were able to apply up
to 100 ug of liver nuclear extract protein for the
immunoblotting assay, but this may not be sufficient for
the detection of native protein from the result described
here.
The reason the immunoreactive LXRα protein level is so
low remains an open question, but previous difficulties
with the study of the native LXRα protein are explainable
based on this low protein level. LXRα is known to func-
tion as a heterodimer. In order to understand the delicate
function of the LXRα protein in actual human cells, care-
ful consideration and some novel technique will be need-
ed to precisely assess the amount of the LXRα protein.
Figure 3
Immunohistochemistry of LXRα protein in LXRα transiently transfected COS-7 cells Human LXRα transfected 
COS-7 cells were fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. After fixation, the sections were 
treated as described previously.Nuclear Receptor 2003, 1 http://www.nuclear-receptor.com/content/1/1/1
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Studies on the intracellular processing and/or degradation
of the LXRα protein will be important future studies. The
mAb K-8607 will be a critical tool for any such
investigation.
Conclusions
In summary, a mAb K-8607 was established which specif-
ically detects human LXRα protein expressed in COS-7
cells or native human LXRα protein in monocyte-derived
macrophages. The native human LXRα protein detected
had an apparent MW of 50,000, which is close to the cal-
culated 447 amino acids in the predicted LXRα protein.
The preponderance of human LXRα protein in COS-7
cells is located in the nucleus. The expression level of na-
tive human LXRα protein is very low as compared with its
heterodimeric partner, RXRα.
Methods
Cell culture
Human primary monocytes / macrophages were obtained
as previously described [5] and maintained in RPMI 1640
medium supplemented with 10% fetal bovine serum
(FBS).
Establishment of antibody
Monoclonal antibody for human LXRα K-8607 was estab-
lished as described previously [21]. Briefly, the N-terminal
sequence of the human LXRα cDNA encoding amino ac-
ids 4–97 was inserted into a baculoviral transfer vector.
Recombinant virus was produced and was purified and
then immunized. After ELISA screening mAB K-8607 was
obtained. Monoclonal antibody for human LXRβ K-8917
was obtained by same method using the transfer vector in-
serted human LXRβ cDNA encoding amino acids 2–86.
Transient transfection
COS-7 cells were cultured in Dulbecco's modified Eagle's
medium (DMEM) containing 10% FBS. Cells were plated
in a 100 mm dish at 2.0 × 106 cells/dish for 16 hours prior
to transfection. Transfections were performed by Effectene
transfection reagent (QIAGEN) using 2 µg of the pcDNA3-
hLXRα expression vector.
Immunoblotting
Nuclear extracts were obtained as previously described
[22]. Aliquots of each sample were separated on a 10%
SDS-polyacrylamide gel and transferred to PVDF mem-
brane. As a control for the correct LXRα protein band, we
used a nuclear extract (2 µg protein) of pcDNA3-LXRα
transfected COS-7 cells.
LXRα proteins were immunochemically detected using
mAb K-8607 (1 µg/ml), and signal detection was achieved
with a Super Signal West Dura Extended Duration
Substrate.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA was performed with nuclear or whole cell extracts
from transiently transfected COS-7 cells and T4 polynu-
cleotide kinase end-labeled oligonucleotides. 10 µg nucle-
ar extracts were incubated with 10 fmol of [gamma-32P]
labeled DR4 with or without a 200-fold molar excess of
cold competitor oligonucleotide in a 15 µL reaction in
EMSA binding buffer (10 mM Tris-HCl pH 7.5, 50 mM
KCl, 10 mM EDTA, 1 mM DTT, 1% Glycerol) for 30 min
on ice. Supershift assays were performed by adding anti-
bodies 30 min before or after incubation with an oligonu-
cleotide probe. Protein-DNA complexes were resolved by
electrophoresis on 4% polyacrylamide gel in 0.5 × TBE.
Following electrophoresis, gels were fixed with 10%
methanol / 10% acetic acid, transferred to moistened filter
paper, dried by heating at 80 C under vacuum, and ex-
posed to the imaging plate. The following double-strand-
ed oligonucleotides were synthesized and used in the
EMSA (sense strand shown): DR4, GATCTTAGTTCACT-
CAAGTTCA-AGGATC; mutated LXRE,
GATCTTGGTCCAGGCAAGTTCTAGGATC.
Immunohistochemistry
COS-7 and human LXRα transfected cells were fixed in
4% paraformaldehyde in PBS for 10 min at room temper-
ature. After fixation, the sections were treated as described
previously [21].
Figure 4
Immunoblot detection of LXRα in human monocytes 
and macrophages using anti-LXRα mAb Nuclear 
extracts of monocytes and macrophages (75 µg per lane) 
were separated on a SDS-polyacrylamide gel (10%), sub-
jected to electrophoresis and transferred to PVDF mem-
brane. Lanes: 1, Control; 2, monocytes; 3, macrophages.Publish with BioMed Central    and   every 
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